WHO ICTRP trial
Rectally administered micronized progesterone for luteal phase support in…
CTIS2023-504616-15-02 · EU Clinical Trials Information System · Not Recruiting
Key facts
| Trial ID | CTIS2023-504616-15-02 |
|---|---|
| Public title | Rectally administered micronized progesterone for luteal phase support in hormone replacement therapy frozen embryo transfer (HRT-FET) cycle – non-inferiority randomized controlled trial |
| Scientific title | Rectally administered micronized progesterone for luteal phase support in hormone replacement therapy frozen embryo transfer (HRT-FET) cycle – non-inferiority randomized controlled trial |
| Primary sponsor | Fertiltetsklinikken, Regionshospitalet Skive |
| Registry | EU Clinical Trials Information System |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): no Therapeutic confirmatory - (Phase III): yes Therapeutic use - (Phase IV): no |
| Countries | Denmark |
| Conditions | Infertility;Therapeutic area: Diseases [C] - Female Urogenital Diseases and Pregnancy Complications [C13] |
| Interventions | Product Name: Cyclogest 400mg,Product Code: PRD6391564,Pharmaceutical Form: PESSARY,Other descriptive name: ,Strength: Progesterone Ph. Eur. 400mg,Product Name: Estrofem 2 mg Filmtabletten,Product Code: PRD1608213,Pharmaceutical Form… |
| Registration date | Nov 9, 2023 |
| Target size | 618 |
| Registry page | euclinicaltrials.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: